Research

As a practice, we are true believers that excellence in performing all eye procedures is derived from both education and experience. We strive to keep current on the latest techniques and standards so we can provide our patients with the safest treatments and procedures with the most optimal results

Dr. Pramanik serves as principal investigator in many clinical trials at the national level. These trials have investigated new treatments for Keratoconus, Fuchs' Dystrophy and many other corneal disorders. The efforts of our patients and staff contribtute to many modern treatment regimens used for these corneal disorders. Presently Dr. Pramanik and his staff are involved in multiple research studies.

Zoster Eye Disease Study (ZEDS) (recently funded but has has not yet begun)

Shingles, also known as Herpes Zoster, is caused by reactivation of the chicken pox virus. It is becoming more common. This study aims to evaluate the long-term suppressive ability of the anti-viral drug, Valacyclovir, in order to treat Herpes Zoster Ophthalmicus (HZO). Read more about Herpes Zoster here.

Diabetes Endothelial Keratoplasty Study (DEKS) (awaiting funding and has not yet begun)

As the rates of diabetes in the U.S. is rising rapidly, this study aims to evaluate the safety in using diabetic donor tissue for corneal transplantation. Read more about Corneal Transplantation here.

Collagen Cross-Linking Phase IV Clinical Trials (CXL) (recruiting)

For an individual with keratoconus, pellucid marginal degeneration, post-refractive surgery ectasia, and patients with corneal ulcers who have failed standard medical therapy. Read More about CXL here.

Cornea Preservation Time Study (CPTS) (ongoing, not actively recruiting)
For adults who are 30-85 years of age in need of a corneal transplant.